Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Nkarta, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Nkarta, Inc. is a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies for cancer treatment. The company focuses on creating allogeneic, off-the-shelf NK cell therapies using its proprietary cellular engineering platform.